CONMED Corp — Director's Dealing 2010

Jun 3, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2010-06-01

Reporting Person: CORASANTI JOSEPH J (President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-06-01	Common Stock	M	5000	—	Acquired	54740	Direct
2010-06-01	Common Stock	F	1811	—	Disposed	52929	Direct
2010-06-01	Common Stock	M	5000	—	Acquired	57929	Direct
2010-06-01	Common Stock	F	1811	—	Disposed	56118	Direct
2010-06-01	Common Stock	M	4000	—	Acquired	60118	Direct
2010-06-01	Common Stock	F	1449	—	Disposed	58669	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-06-01	Rsus (restricted Stock Units)	$0	M	5000	Disposed	2018-06-01	Common Stock (5000)	Direct
2010-06-01	Rsus (restricted Stock Units)	$0	M	5000	Disposed	2019-06-01	Common Stock (5000)	Direct
2010-06-01	Rsus (restricted Stock Units)	$0	M	4000	Disposed	2019-10-30	Common Stock (4000)	Direct
2010-06-01	Rsus (restricted Stock Units)	$0	A	25000	Acquired	2020-06-01	Common Stock (25000)	Direct
2010-06-01	Sars (Stock Appreciation Rights)	$19.26	A	62500	Acquired	2020-06-01	Common Stock (62500)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per
share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2006 Stock
Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year
after the grant date.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.

F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting 20% each year over a five year period with the first 20% tranche to vest on June 1, 2010 with each successive 20% tranche to vest on June 1 the following year.

F4: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.